Vaxxas CEO David Hoey said, “Our HD-MAP technology offers a potential solution to the growing need to significantly expand global access to innovative mRNA vaccines by eliminating the current ultra-cold storage requirements for these vaccines." …
CEPI backing for Vaxxas to advance needle-free thermostable mRNA vaccines
January 23, 2025 Latest NewsAustralian Biotech
Latest Video
New Stories
-
The 'Dispatched' Week in Review Podcast - 17 April
April 17, 2026 - - Podcast -
Australia, the US, and their different choices about health system trade-offs
April 17, 2026 - - Latest News -
Why hospitals, and not medicines, dominate America’s health spending gap
April 17, 2026 - - Latest News -
New strategic alliance for Biointelect aims to fast track life sciences innovation
April 17, 2026 - - Latest News -
Mark Butler confirms new and expanded cancer medicine listings
April 17, 2026 - - Latest News -
Why US health spending looks much higher than it really is
April 16, 2026 - - Latest News -
Pharmacy prescribing reform signals shift in NSW primary care with Victoria to follow
April 15, 2026 - - Latest News